Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRSS57 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-08 |
mRNA | PAFAH1B3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | NPIPA5 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | RFX7 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | MAPK8IP2 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | ZNF607 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | ZNF627 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | TOX | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
mRNA | PSD | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | SLC25A29 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |